The EEOICPA was passed in 2000. It provides compensation to workers who became ill as a result of their employment manufacturing nuclear weapons in the USA, as well as their spouses, children, and grandchildren. Titanium Alloys Manufacturing EEOICPA coverage is available for qualified former Workers and their families.

Are you eligible for compensation? If you or a family member worked at this or another AWE facility and became ill, you may be entitled to compensation of up to $150K plus medical benefits. Call EEOICPA Counsel Hugh Stephens at 1-855-548-4494 or fill out our free claim evaluation, We can help even if you’ve already filed, even if your claim was denied!

Here, we have compiled publicly available information and documentation about the facilities covered by the Act to clarify how their activities relate to the Energy Employees Occupational Illness Compensation Program Act.

Titanium Alloys Manufacturing

Also Known As: Humphreys Gold Co., Titanium Alloys Mfg Co, Div. Of National Lead, Titanium Alloy Metals , Titanium Pigment Co.
State: New York
Location: Niagara Falls
Time Period: 1955-1956
Facility Type: Atomic Weapons Employer

Facility Description: Titanium Alloys Manufacturing (TAM) processed uranium-contaminated scrap associated with the nuclear weapons production process in 1955-1956. TAM also worked with zirconium tetrachloride for National Lead of Ohio starting 1950, but because zirconium tetrachloride is not radioactive, this work is not covered under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA).

Titanium Alloys Manufacturing is listed as an Atomic Weapons Employer (AWE) site under the EEOICPA.

As of 05/25/2015, the total compensation paid under Part B of the EEOICPA, including medical compensation, for workers suffering from the effects of having worked at Titanium Alloys Manufacturing is $605,245.

NIOSH SEC Petition Evaluation Reports
Petition 190 (Jan 1, 1955, to Dec 31, 1956)
SEC Petition Evaluation Report, Petition SEC-00190
Report Submittal Date: 02/13/2012, Report Rev #:0